C. Tuerk and L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, vol.249, issue.4968, pp.505-510, 1990.
DOI : 10.1126/science.2200121

A. Ellington and J. Szostak, In vitro selection of RNA molecules that bind specific ligands, Nature, vol.346, issue.6287, pp.818-822, 1990.
DOI : 10.1038/346818a0

H. Ulrich, M. Magdesian, M. Alves, and W. Colli, In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell Invasion, Journal of Biological Chemistry, vol.277, issue.23, pp.20756-20762, 2002.
DOI : 10.1074/jbc.M111859200

J. Wang, H. Jiang, and F. Liu, In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection, RNA, vol.6, issue.4, pp.571-583, 2000.
DOI : 10.1017/S1355838200992215

C. Wang, M. Zhang, G. Yang, D. Zhang, and H. Ding, Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment, Journal of Biotechnology, vol.102, issue.1, pp.15-22, 2003.
DOI : 10.1016/S0168-1656(02)00360-7

L. Cerchia, J. Hamm, D. Libri, B. Tavitian, and V. De-franciscis, Nucleic acid aptamers in cancer medicine, FEBS Letters, vol.37, issue.1-3, pp.12-16, 2002.
DOI : 10.1016/S0014-5793(02)03275-1

M. Blank, T. Weinschenk, M. Priemer, and H. Schluesener, Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels: SELECTIVE TARGETING OF ENDOTHELIAL REGULATORY PROTEIN PIGPEN, Journal of Biological Chemistry, vol.276, issue.19, pp.16464-16468, 2001.
DOI : 10.1074/jbc.M100347200

D. Daniels, H. Chen, B. Hicke, K. Swiderek, and L. Gold, A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment, Proceedings of the National Academy of Sciences, vol.279, issue.8, pp.15416-15421, 2003.
DOI : 10.1007/s002590050397

D. Wilson and J. Szostak, In Vitro Selection of Functional Nucleic Acids, Annual Review of Biochemistry, vol.68, issue.1, pp.611-647, 1999.
DOI : 10.1146/annurev.biochem.68.1.611

B. Hicke, C. Marion, Y. Chang, T. Gould, and C. Lynott, Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein, Journal of Biological Chemistry, vol.276, issue.52, pp.48644-48654, 2001.
DOI : 10.1074/jbc.M104651200

R. Sousa, [4] Use of T7 RNA polymerase and its mutants for incorporation of nucleoside analogs into RNA, Methods Enzymol, vol.317, pp.65-74, 2000.
DOI : 10.1016/S0076-6879(00)17006-5

J. Ruckman, L. Green, J. Beeson, S. Waugh, and W. Gillette, 2'-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165): INHIBITION OF RECEPTOR BINDING AND VEGF-INDUCED VASCULAR PERMEABILITY THROUGH INTERACTIONS REQUIRING THE EXON 7-ENCODED DOMAIN, Journal of Biological Chemistry, vol.273, issue.32, pp.20556-20567, 1998.
DOI : 10.1074/jbc.273.32.20556

K. Thiel, Oligo oligarchy???the surprisingly small world of aptamers, Nature Biotechnology, vol.14, issue.6, pp.649-651, 2004.
DOI : 10.1038/374546a0

A. Gschwind, O. Fischer, and A. Ullrich, Timeline: The discovery of receptor tyrosine kinases: targets for cancer therapy, Nature Reviews Cancer, vol.4, issue.5, pp.361-370, 2004.
DOI : 10.1038/nrc1360

S. Manie, M. Santoro, A. Fusco, and M. Billaud, The RET receptor: function in development and dysfunction in congenital malformation, Trends in Genetics, vol.17, issue.10, pp.580-589, 2001.
DOI : 10.1016/S0168-9525(01)02420-9

M. Takahashi, The GDNF/RET signaling pathway and human diseases, Cytokine & Growth Factor Reviews, vol.12, issue.4, pp.361-373, 2001.
DOI : 10.1016/S1359-6101(01)00012-0

M. Ichihara, Y. Murakumo, and M. Takahashi, RET and neuroendocrine tumors, Cancer Letters, vol.204, issue.2, pp.197-211, 2004.
DOI : 10.1016/S0304-3835(03)00456-7

J. Hansford and L. Mulligan, Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis, Journal of Medical Genetics, vol.37, issue.11, pp.817-827, 2000.
DOI : 10.1136/jmg.37.11.817

B. Putzer and M. Drosten, The RET proto-oncogene: a potential target for molecular cancer therapy, Trends in Molecular Medicine, vol.10, issue.7, pp.351-357, 2004.
DOI : 10.1016/j.molmed.2004.06.002

D. Califano, D. 'alessio, A. Colucci-d-'amato, G. , D. Vita et al., A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells., Proceedings of the National Academy of Sciences, vol.93, issue.15, pp.7933-7937, 1996.
DOI : 10.1073/pnas.93.15.7933

K. Morris, K. Jensen, C. Julin, M. Weil, and L. Gold, High affinity ligands from in vitro selection: Complex targets, Proceedings of the National Academy of Sciences, vol.273, issue.5274, pp.2902-2907, 1998.
DOI : 10.1126/science.273.5274.464

L. Cerchia, D. Libri, M. Carlomagno, and V. De-franciscis, The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret, Biochemical Journal, vol.372, issue.3, pp.897-903, 2003.
DOI : 10.1042/bj20021530

M. Santoro, F. Carlomagno, A. Romano, D. Bottaro, and N. Dathan, Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B, Science, vol.11, issue.1, pp.381-383, 1995.
DOI : 10.1016/0092-8674(77)90333-6

G. Colucci-d-'amato, D. 'alessio, A. Califano, D. Cali, G. Rizzo et al., Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK, Journal of Biological Chemistry, vol.275, issue.25, pp.19306-19314, 2000.
DOI : 10.1074/jbc.275.25.19306

U. Bhalla, P. Ram, and R. Iyengar, MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network, Science, vol.297, issue.5583, pp.1018-1023, 2002.
DOI : 10.1126/science.1068873

F. Carlomagno, R. Melillo, R. Visconti, G. Salvatore, D. Vita et al., Glial Cell Line-Derived Neurotrophic Factor Differentially Stimulates Ret Mutants Associated with the Multiple Endocrine Neoplasia Type 2 Syndromes and Hirschsprung's Disease, Endocrinology, vol.139, issue.8, pp.3613-3619, 1998.
DOI : 10.1210/en.139.8.3613

C. Rizzo, D. Califano, G. Colucci-d-'amato, D. Vita, G. et al., Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B, J Biol Chem, vol.271, pp.29497-29501, 1996.

A. Levi, J. Eldridge, and B. Paterson, Molecular cloning of a gene sequence regulated by nerve growth factor, Science, vol.229, issue.4711, pp.393-395, 1985.
DOI : 10.1126/science.3839317

C. Chen, G. Chernis, V. Hoang, and R. Landgraf, Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3, Proceedings of the National Academy of Sciences, vol.300, issue.5620, pp.9226-9231, 2003.
DOI : 10.1126/science.1082024

M. Barnett, C. Fisher, G. Perona-wright, and J. Davies, Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan, Journal of Cell Science, vol.115, issue.23, pp.4495-4503, 2002.
DOI : 10.1242/jcs.00114
URL : http://jcs.biologists.org/cgi/content/short/115/23/4495

D. 'alessio, A. Califano, D. Incoronato, M. Santelli, G. Florio et al., The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants, Endocrinology, vol.144, pp.4298-4305, 2003.

T. Fitzwater and B. Polisky, [17] A SELEX primer, Methods Enzymol, vol.267, pp.275-301, 1996.
DOI : 10.1016/S0076-6879(96)67019-0

D. Bartel and J. Szostak, Isolation of new ribozymes from a large pool of random sequences [see comment], Science, vol.261, issue.5127, pp.1411-1418, 1993.
DOI : 10.1126/science.7690155